Single Cell Analysis Market, By Cell Type (Human, Animal, and Microbial), By Technique (Flow Cytometry, Next-generation Sequencing, PCR, Microscopy, Mass Spectroscopy, and Others), By Application (Research (Cancer, Immunology, Neurology, Stem Cell, and Others), and Medical (Non-Invasive Prenatal Diagnosis, In Vitro Fertilization, Circulating Tumor Cell, and Detection)), By End User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, and Hospital and Diagnostic Laboratories), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Single-Cell Analysis Market accounted for US$ 2.5 billion in 2020 and is estimated to be US$ 8.4 billion by 2030 and is anticipated to register a CAGR of 13.1%.

Single-cell analysis is the study of genomics, transcriptomics, proteomics and metabolomics at the single-cell level. It is critically important in disclosing population heterogeneity, identifying market sub-populations of interest, as well as discovering unique characteristics of individual cells. It is applied in cancer research for various chronic and infectious diseases. Single-cell analysis systemizes the workflow with beneficial information for real-time monitoring of cancer and the new therapeutic strategies for the benefit of patients.

Growing focus on personalized medicine and increasing government funding for cell-based research are propelling the single-cell analysis market growth. Also, technological advancement in single-cell analysis cell types will help in rescuing the increasing incidence and prevalence of chronic and infectious disease which in return contributing to the growth of the target market. These technological advancements are widening the applications of single-cell analysis and are offering end-users with advanced and easy-to-use solutions for various research purposes. As a result, several newly launched cell types in the market are expected to generate significant consumer interest in the coming years, thus supporting the growth of the single-cell analysis market. The rise in the biotechnology and biopharmaceutical industries is also supporting to boost the growth of a single-cell analysis market. However, the high cost of single-cell analysis cell type and technology is restraining the target market growth. There are various issues related to intellectual property rights and increasing key player’s competition for the new entrants in the market is also hindering the growth of the market.

The single-cell analysis market is segmented based on cell type, technique, application, end-user and region.

Based on cell type, the single-cell analysis market is segmented into the human, animal, and microbial. Based on the technique, the target market is segmented into flow cytometry, next-generation sequencing, PCR, microscopy, mass spectroscopy, and others. Based on the application, the target market is bifurcated into research and medical. Research application segment is further divided into cancer, immunology, neurology, stem cell, & others. Medical application segment is further bifurcated into a non-invasive prenatal diagnosis, in vitro fertilization, circulating tumour cell, detection. Cancer research is considered as one of the major driving factors for the target market over the forecast period. Whereas immunology research application is expected to grow with high CAGR during the forecast period. Based on end-user, the single-cell analysis market is classified into academic and research laboratories, biotechnology and pharmaceutical companies, and hospital & diagnostic laboratories.

Regional Insights:                                

Based on the region the single-cell analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the single-cell analysis market due to growing demand for advanced medical technologies and increasing geriatric population. Asia Pacific single-cell analysis market is projected to register a high CAGR over the forecast period owing to the growing trend invasion metabolic activities of single cells and increasing the adoption of its analytical tools.                        

Single Cell Analysis Market, By Cell type:

• Human
• Animal
• Microbial

Single Cell Analysis Market, By Technique:

• Flow Cytometry
• Next-Generation Sequencing
• PCR
• Microscopy
• Mass Spectroscopy
• Others

Single Cell Analysis Market, By Application:

• Research
  • Cancer
  • Immunology
  • Neurology
  • Stem Cell
  • Others
• Medical
  • Non-Invasive Prenatal Diagnosis
  • In Vitro Fertilization
  • Circulating Tumor Cell
  • Detection

Single Cell Analysis Market, By End-user:

• Academic & Research Laboratories
• Biotechnology and Pharmaceutical Companies
• Hospital & Diagnostic Laboratories.

Single Cell Analysis Market, By Region:

• North America
  • Middle East & Africa
    • Middle East & Africa  Single Cell Analysis  Market, By Cell type
    • Middle East & Africa  Single Cell Analysis  Market, By Technique
    • Middle East & Africa  Single Cell Analysis  Market, By Application
    • Middle East & Africa  Single Cell Analysis  Market, By End-user
    • Middle East & Africa  Single Cell Analysis  Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • Latin America  Single Cell Analysis  Market, By Cell type
    • Latin America  Single Cell Analysis  Market, By Technique
    • Latin America  Single Cell Analysis  Market, By Application
    • Latin America  Single Cell Analysis  Market, By End-user
    • Latin America  Single Cell Analysis  Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • Asia Pacific  Single Cell Analysis  Market, By Cell type
    • Asia Pacific  Single Cell Analysis  Market, By Technique
    • Asia Pacific  Single Cell Analysis  Market, By Application
    • Asia Pacific  Single Cell Analysis  Market, By End-user
    • Asia Pacific  Single Cell Analysis  Market, By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • Europe  Single Cell Analysis  Market, By Cell type
    • Europe  Single Cell Analysis  Market, By Technique
    • Europe  Single Cell Analysis  Market, By Application
    • Europe  Single Cell Analysis  Market, By End-user
    • Europe  Single Cell Analysis  Market, By Country
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • North America  Single Cell Analysis  Market, By Cell type
  • North America  Single Cell Analysis  Market, By Technique
  • North America  Single Cell Analysis  Market, By Application
  • North America  Single Cell Analysis  Market, By End-user
  • North America  Single Cell Analysis  Market, By Country
    • U.S.
    • Canada

The key players operating the single-cell analysis market involves Illumina Inc., Beckman Coulter Inc., Becton, Dickinson, & Company, Bio-Rad Laboratories Inc., GE Healthcare, Merck KGaA, Promega Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Milyenyi Biotech. For instance, in February 2017, BD (Becton, Dickinson and Company) announced the early access program for the BD Resolve Single-Cell Gene Expression platform that can capture and analyze hundreds to tens of thousands of individual cells in a broad range of sizes and types. In January 2017, Bio-Rad Laboratories, Inc. and Illumina, Inc. launched the Illumina Bio-Rad Single-Cell Sequencing Solution. This is the first next-generation sequencing (NGS) workflow for the single-cell analysis of individual cells in tissue function, disease progression, and therapeutic response.

• Illumina Inc.
• Beckman Coulter Inc.
• Becton, Dickinson, & Company
• Bio-Rad Laboratories Inc.
• GE Healthcare
• Merck KGaA
• Promega Corporation
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Milyenyi Biotech